{
  "url": "https://openlegislation.uk/medicines-for-human-use-marketing-authorisations-etc-amendment-regulations-2000/regulation-5",
  "json_url": "https://openlegislation.uk/medicines-for-human-use-marketing-authorisations-etc-amendment-regulations-2000/regulation-5.json",
  "legislation": "uksi/2000/292",
  "legislation_title": "The Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2000",
  "legislation_url": "https://openlegislation.uk/medicines-for-human-use-marketing-authorisations-etc-amendment-regulations-2000",
  "path": "regulation/5",
  "kind": "regulation",
  "number": "5",
  "heading": "Amendment of Schedule 5 to the principal Regulations",
  "text": "In paragraph 5(1) of Schedule 5 to the principal Regulations (labels—relevant medicinal products on a general sale list), in paragraphs (f)(i) and (g)(i), for the word “case”, at each place where it occurs, there shall be substituted the word “event”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Amended by S.I. 1998/3105."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2000/292/regulation/5",
    "retrieved_at": "2026-10-29T09:21:15.854764+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}